Clinical Trial Update: Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated MP-513 in combination with metformin for type 2 diabetes and has posted efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MP-513
• metformin (metformin)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2014-09-01